ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 102 filers reported holding ANTARES PHARMA INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $7,454,000 | -73.6% | 3,745,662 | -57.0% | 0.25% | -54.2% |
| Q3 2017 | $28,214,000 | +105.3% | 8,707,794 | +104.1% | 0.54% | -22.0% |
| Q2 2017 | $13,741,000 | +65.9% | 4,267,253 | +46.3% | 0.69% | +46.4% |
| Q1 2017 | $8,285,000 | +21.9% | 2,917,253 | 0.0% | 0.47% | -2.3% |
| Q4 2016 | $6,797,000 | +645.3% | 2,917,253 | – | 0.48% | +718.6% |
| Q3 2016 | $912,000 | – | 0 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |